MedTrace Logo

ECG Monitoring Short vs Middle Term After Atrial Fibrillation Ablation

NCT05959915 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2025-07-10

No results posted yet for this study

Summary

To compare the number of patients with AF recurrence detected in a 24-h Holter monitoring with a 5-day record.

Conditions

Interventions

DEVICE

device e-patch Implantation

The ePatch device (Phillips) was used. This device is attached to the sternum, using a specific dressing adapted for the device itself. Manufacturer's recommendations for skin preparation and placement will be followed. The device will remain in place for 4-5 days, at which time the patient will be readmitted for data extraction and reading. The team of research nurses will analyze the data through the ePatch platform and later, the electrophysiologists will review the results and make a diagnosis.

Sponsors & Collaborators

  • Hospital Clinic of Barcelona

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-07-01
Completion
2025-06-01
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05959915 on ClinicalTrials.gov